Researcher.Life Logo

Neurology: Neuroimmunology and NeuroInflammation : Impact Factor & More

eISSN: 2332-7812pISSN: 2332-7812
JournalOpen Access

Key Metrics

CiteScore
9.1
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
Scite Index
0.86 5-Year SI
SJR
Q1Neurology
SNIP
1.85
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neurology: Neuroimmunology and NeuroInflammation

Neurology: Neuroimmunology and NeuroInflammation Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Bi-monthly
Article Processing ChargesUSD 3450
Publication Time8
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorAmerican Academy of Neurology
FrequencyBi-monthly
Publication Start Year2014
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 8
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Neurology: Neuroimmunology and NeuroInflammation ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neurology: Neuroimmunology and NeuroInflammation

Peripheral Immune Remodeling After Spinal Cord Injury: Marked by Expansion of CD38+, CTLA-4+, and PD-1+ T and NK Cells.
  • 1 Mar 2026
  • Neurology(R) neuroimmunology & neuroinflammation
Progression Independent of Relapse Activity in Aquaporin-4-IgG-Positive NMOSD: A Decade-Long Cohort Study.
  • 1 Mar 2026
  • Neurology(R) neuroimmunology & neuroinflammation
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments.
  • 1 Mar 2026
  • Neurology(R) neuroimmunology & neuroinflammation
Validation of the MOG-AR Score: A Retrospective Multicenter Study.
  • 1 Mar 2026
  • Neurology(R) neuroimmunology & neuroinflammation
OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.
  • 1 Mar 2026
  • Neurology(R) neuroimmunology & neuroinflammation
Nasal Foralumab for the Treatment of Progression Independent of Relapses in Patients With Nonactive Secondary Progressive Multiple Sclerosis
  • 16 Jan 2026
  • Neurology® Neuroimmunology & Neuroinflammation
Peripheral Immune Remodeling After Spinal Cord Injury: Marked by Expansion of CD38+, CTLA-4+, and PD-1+ T and NK Cells.
  • 1 Mar 2026
  • Neurology(R) neuroimmunology & neuroinflammation
Progression Independent of Relapse Activity in Aquaporin-4-IgG-Positive NMOSD: A Decade-Long Cohort Study.
  • 1 Mar 2026
  • Neurology(R) neuroimmunology & neuroinflammation
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments.
  • 1 Mar 2026
  • Neurology(R) neuroimmunology & neuroinflammation
Validation of the MOG-AR Score: A Retrospective Multicenter Study.
  • 1 Mar 2026
  • Neurology(R) neuroimmunology & neuroinflammation
OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.
  • 1 Mar 2026
  • Neurology(R) neuroimmunology & neuroinflammation
Nasal Foralumab for the Treatment of Progression Independent of Relapses in Patients With Nonactive Secondary Progressive Multiple Sclerosis
  • 16 Jan 2026
  • Neurology® Neuroimmunology & Neuroinflammation

FAQs on Neurology: Neuroimmunology and NeuroInflammation